Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Average Rating of “Moderate Buy” by Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been given a consensus recommendation of “Moderate Buy” by the twenty-seven research firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation, sixteen have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $622.1667.

A number of brokerages have commented on ISRG. Robert W. Baird set a $655.00 price target on Intuitive Surgical in a research report on Wednesday, October 22nd. Argus raised their price objective on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $740.00 target price (up previously from $700.00) on shares of Intuitive Surgical in a report on Friday. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 22nd. Finally, Rothschild & Co Redburn lifted their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd.

Intuitive Surgical Stock Up 0.2%

ISRG stock opened at $586.24 on Monday. The stock has a market capitalization of $210.16 billion, a PE ratio of 77.55, a price-to-earnings-growth ratio of 4.77 and a beta of 1.67. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a 50 day moving average of $565.95 and a 200 day moving average of $511.38.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter last year, the company posted $1.84 earnings per share. On average, equities research analysts expect that Intuitive Surgical will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the sale, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 7,562 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $193,595.79. The trade was a 95.54% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 114,007 shares of company stock valued at $63,533,844 over the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently bought and sold shares of ISRG. Trust Co. of Oklahoma acquired a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $363,000. IronOak Wealth LLC. acquired a new stake in shares of Intuitive Surgical in the second quarter worth approximately $1,099,000. Eastover Investment Advisors LLC grew its holdings in Intuitive Surgical by 204.8% in the second quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after purchasing an additional 8,844 shares during the period. Amalgamated Bank increased its position in Intuitive Surgical by 2.2% during the second quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after purchasing an additional 1,772 shares during the last quarter. Finally, SteelPeak Wealth LLC increased its position in Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after purchasing an additional 9,364 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.